Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 9;4(4):1-7.
doi: 10.1093/ehjcr/ytaa124. eCollection 2020 Aug.

An unusual case of severe myocarditis in a genetic cardiomyopathy: a case report

Affiliations
Case Reports

An unusual case of severe myocarditis in a genetic cardiomyopathy: a case report

Miruna-Andreea Popa et al. Eur Heart J Case Rep. .

Abstract

Background: Myocarditis is an inflammatory disease of the myocardium caused by infectious pathogens, immune-mediated conditions, or toxic agents. This report explores a rare case of severe myocarditis occurring in an inherited cardiomyopathy.

Case summary: A 24-year-old female patient presented with progressing dyspnoea and chest discomfort. Echocardiography and cardiac magnetic resonance imaging revealed dilated cardiomyopathy (DCM) with severe biventricular dysfunction [left ventricle ejection fraction (LV-EF) 10%]. Myocardial inflammation was suspected due to extensive subendocardial to transmural late gadolinium enhancement. Endomyocardial biopsy (EMB) showed severe chronic lymphocytic myocarditis. As inflammatory DCM was assumed, immunosuppressive therapy with prednisolone was initiated in addition to standard heart failure therapy. Endomyocardial biopsy after 3 months showed resolving inflammation. However, a marked architectural disarray observed in all biopsies raised the suspicion of an inherited cardiomyopathy. Genetic testing revealed a de novo mutation with effect on splicing of lysosome-associated membrane protein 2, as found in Danon disease. Periodic acid-Schiff (PAS) staining confirmed a glycogen storage disorder. Immunosuppressive therapy was intensified due to reactivation of myocardial inflammation and led to improvement of LV-EF and to significant symptom relief over a 16-month follow-up period.

Discussion: This is the first report of Danon disease initially presenting as a severe myocarditis. It illustrates the clinical value of EMB for diagnosis and immunosuppressive therapy monitoring in chronic myocarditis. Increasing evidence suggests that myocardial inflammation may modify disease progression and prognosis in inherited cardiomyopathies. The causal role of cardiac protein mutations in the pathophysiology of myocarditis remains to be determined.

Keywords: Case report; Danon disease; Dilated cardiomyopathy; Endomyocardial biopsy; Inherited cardiomyopathies; Lymphocytic myocarditis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Twelve-lead electrocardiogram at initial presentation. (A) Atrial fibrillation with wide QRS complexes (170 ms) presenting both right and left bundle branch block pattern (64 b.p.m.), indicative of severe conduction abnormalities and ventricular extrasystoles. (B) Electrocardiogram after spontaneous conversion to sinus rhythm. The partial atrioventricular dissociation (P-waves indicated by arrows) and deformed QRS complexes are suggestive of complete heart block with junctional escape rhythm (47 b.p.m.).
Figure 2
Figure 2
Representative transthoracic echocardiogram images. Severely dilated left ventricle shown in parasternal long axis (PLAX) end-diastolic (A) and end-systolic (B) view. Interventricular septal wall thickness in diastole 11 mm, left ventricular end-diastolic diameter 64 mm, left ventricular end-systolic diameter 57 mm, and posterior wall thickness in end-diastole 8 mm. Severe functional mitral regurgitation (four-chamber view) with broad regurgitation jet as seen in colour Doppler (C), quantified using the proximal isovelocity surface area method (D).
Figure 3
Figure 3
Representative cardiac magnetic resonance images in short-axis view and four-chamber view. Dilated left ventricle with markedly reduced global ejection fraction (10%) and akinesia of the thin basal anteroseptal and apical inferior wall. Both areas show transmural late enhancement. In addition, subendocardial and subepicardial enhancement can be observed in the anterolateral and inferolateral wall, respectively. The inferior septum presents predominantly mid-myocardial enhancement. Furthermore, a marked increase in extracellular volume is observed in these areas (up to 60%). T2-TSE shows an increased signal intensity in the mid-cavity septum (three-fold increase compared to the pectoral muscle). The T2-relaxation time (54 ms) determined in T2-mapping is in the normal range. 4ch, four-chamber view; ECV, extracellular volume; LGE, late gadolinium enhancement; SAX, short-axis view.
Figure 4
Figure 4
Histological findings in endomyocardial biopsies. Immunohistochemical staining detects numerous CD3+ T cells (A and C). Masson trichrome stain reveals myofiber disarray, loss of myofibrils, and fibrosis (B and D). PAS staining illustrates glycogen deposits within cardiomyocytes without (E and G) and with (F and H) diastase digestion. Magnification A–D, G and H ×200, E and F ×400. EMB, endomyocardial biopsy; IHC, immunohistochemistry; PAS, periodic acid-Schiff.
None

References

    1. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM.. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–2648, 2648a–2648d. - PubMed
    1. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, d'Amati G, Edwards WD, Fallon JT, Fishbein MC, Gallagher PJ, Halushka MK, McManus B, Pucci A, Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C, Thiene G, van der Wal AC, Winters GL.. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 2012;21:245–274. - PubMed
    1. Buggey J, ElAmm CA.. Myocarditis and cardiomyopathy. Curr Opin Cardiol 2018;33:341–346. - PubMed
    1. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG.. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352:362–372. - PubMed
    1. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M.. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000;406:906–910. - PubMed

Publication types

LinkOut - more resources